	Immune checkpoints in lung cancer. Breathe (Sheff) Garrido-Martín EM, Kontic M, Rooney C, Mansouri N. PMID: 42164238 [PubMed]
	Tumor Regression Following Neoadjuvant Therapy as a Determinant of Surgical Resectability in Stage IIIA Non-small Cell Lung Cancer: A Comparative Clinical Study. Cureus Musanovic S, Pilav I, Pilav A, Custovic O, Zvizdic Z. PMID: 42164225 [PubMed]
	Correlation of Fluorodeoxyglucose (FDG) PET Biomarkers (SUVmax, SUVpeak, TLG, and MTV) With Histopathological and Biochemical Parameters in FDG-Avid Lung Carcinoma. Cureus D A, S P, Panda DK, Kumar S. PMID: 42164190 [PubMed]
	Targeting ferroptosis in lung cancer: pharmacological regulation, nanomedicine-based delivery, and AI-enabled translational strategies. Am J Cancer Res Miao D, Liu J, Shen B, Yang Y. PMID: 42163892 [PubMed]
	From locus to gene: causal inference and experimental validation prioritize PSMA4 as a candidate target in lung adenocarcinoma. Am J Cancer Res Lu H, Wang S, Ma Y, Shen Z, Yao L, Kang N, Si P, Zhang R. PMID: 42163891 [PubMed]
	Predictive value of systemic immune-inflammatory markers for lung cancer-associated cerebral infarction: a retrospective cohort study. Am J Cancer Res Zhu D, Wang H, Yan Z, Zhao J, Sun Y, Zhu D, Zhang P. PMID: 42163874 [PubMed]
	Pulmonary langerhans cell histiocytosis following resection of lung adenocarcinoma: a case report and diagnostic challenges. Am J Cancer Res Liu Y, Duan Z, Liu M, Zhang H, Li Y, Wang M, Zhang H, Chen J, Zhao H. PMID: 42163872 [PubMed]
	Evaluation of the reliability of markerless tumor tracking with single-energy and dual-energy imaging using machine learning. J Appl Clin Med Phys Nguyen H, Luce J, Zhu L, Lehmann M, Kang H, Harkenrider MM, Roeske JC. PMID: 42163784 [PubMed - indexed for MEDLINE]
	The Treg-cell death axis in lung cancer: implications for immune evasion and novel therapeutic strategies. Mol Cancer Fan W, An Q, Wang X, Qin D, Zhao Z, Dong X, Wang L, Wong AL, Yang DH, Goh BC, Dong J. PMID: 42163322 [PubMed - as supplied by publisher]
	A population-based study on the impact of social determinants of health on time to treatment of stage I lung cancer in Ontario, Canada. BMC Cancer Hanna NM, Shakeel S, Akhtar-Danesh GG, Finley C, Akhtar-Danesh N. PMID: 42163198 [PubMed - as supplied by publisher]
	Histological transformation in lung cancer: a single-arm meta-analysis and systematic review. BMC Cancer Hu L, Zhu X, Chen X, Yang F, Jiang S, Guo S, Wei M, Li Z, Shen X. PMID: 42163145 [PubMed - as supplied by publisher]
	Perioperative nebulized budesonide and L-Cysteine reduce pulmonary complications after posterior skull base tumor resection: a randomized controlled trial. BMC Anesthesiol Wu S, Richard SA, Lan Z. PMID: 42163118 [PubMed - as supplied by publisher]
	Comparative Efficacy of Non-Pharmacological Interventions on Fatigue, Depression, and Quality of Life in Patients With Lung Cancer: A Network Meta-Analysis of Randomized Controlled Trials. Worldviews Evid Based Nurs Duan L, Zhang S, Su Y, Li L, Hu M, Hu X. PMID: 42163071 [PubMed - indexed for MEDLINE]
	Pre-analytical standardization and multi-biofluid harmonization for liquid biopsy biomarkers in lung cancer: From discovery to clinical laboratory implementation. Clin Chim Acta Sharapov S, Tolibov M, Khamidova F, Akhmedova S, Khasanov S, Yusufova M, Azizov B, Dustova N, Yokubova M. PMID: 42162904 [PubMed - as supplied by publisher]
	Pembrolizumab with or without chemotherapy among older adults with advanced lung adenocarcinoma: a national, nonrandomized open-label phase II trial (Alliance A171901). J Natl Cancer Inst Wong ML, Lee MK, Kour O, Satele D, Presley CJ, Le-Rademacher J, Ojelabi M, Chow S, Stinchcombe TE, Homan S, Finnes HD, Waqar S, Jatoi A. PMID: 42161344 [PubMed - as supplied by publisher]
	County-Level Structural Racism Indices and Racial Disparities in Lung Cancer Care. JAMA Netw Open Gaddy JJ, Lee DH, Herrin J, Yu JB, Pollack CE, Dean LT, Dougherty GB, Canavan ME, Soulos PR, Gross CP. PMID: 42160049 [PubMed - indexed for MEDLINE]
	Definitive radiotherapy for non-small-cell lung cancer: current practice and future directions. Jpn J Radiol Kishi N, Kimura T, Mizowaki T. PMID: 42159909 [PubMed - as supplied by publisher]
	Arian protocol: a phase iii study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer. Expert Opin Biol Ther Provencio M, Aguiar D, Antoñanzas M, Areses MC, Azkárate A, Barba A, Bernabé R, Blanco R, Borregón M, Campos B, Coves J, de Castro J, Domènech M, Dómine M, García Campelo R, Lucía-Gozálvez C, Lázaro-Quintela M, Insa A, Juan-Vidal Ó, López Castro R, Martínez-Marti A, Medina S, Moreno MÁ, Nadal E, Olivares-Hernández A, Reguart N, Sala MÁ, Medina K, Vila L, Massutí B. PMID: 42159280 [PubMed - as supplied by publisher]
	Association of systemic immune-inflammation index with all-cause mortality in lung cancer patients undergoing radiotherapy: a retrospective cohort study. Front Oncol Yang J, Liu Z, Zhang M. PMID: 42158428 [PubMed]
	Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death. Front Cell Dev Biol Yang Y, Pei W, Ren T, Wang Y, Dai L, Maimaitiaili B, Meng B, Tang Q, Feng H. PMID: 42158287 [PubMed]

Articles 1 - 20 / 159736

Page 1 of 7987



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy